Detection of silent cerebrovascular lesions in individuals with ‘masked’ and ‘white-coat’ hypertension by home blood pressure measurement: the Ohasama study

Objective To investigate the risk of silent cerebrovascular lesions in individuals with masked hypertension (MHT) and white-coat hypertension. Methods Self-measured home blood pressure (HBP) and casual blood pressure (CBP) measurements were recorded in 1060 individuals at least 55 years of age (mean age, 66.3 years) in a general population of Ohasama, Japan. The relationships between silent cerebrovascular lesions (white matter hyperintensity and lacunar infarct) detected on MRI and four blood pressure groups [sustained normal blood pressure (SNBP), HBP <135/85 mmHg, CBP <140/90 mmHg; white-coat hypertension, HBP <135/85 mmHg, CBP ≥140/90 mmHg; MHT, HBP ≥135/85 mmHg, CBP <140/90 mmHg; sustained hypertension, HBP ≥135/85 mmHg, CBP ≥140/90 mmHg] were examined using multivariate analysis adjusted for possible confounding factors. Results The odds ratios of sustained hypertension (1.74, 95% confidence interval 1.18–2.57) and MHT (2.31, 95% confidence interval 1.32–4.04) for the presence of silent cerebrovascular lesions were significantly higher than the odds ratio of SNBP, whereas there was no significant difference between white-coat hypertension and SNBP (1.03, 95% confidence interval 0.75–1.41). The odds ratios for the presence of either lacunar infarct or white matter hyperintensity in the four groups were similar to those for silent cerebrovascular lesions. Conclusion The present study is the first to demonstrate that the risk of silent cerebrovascular lesions is higher with MHT than with SNBP and similar to that of sustained hypertension.

[1]  K. Asayama,et al.  Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study , 2009, Journal of hypertension.

[2]  G. Mancia,et al.  2007 ESH–ESC practice guidelines for the management of arterial hypertension , 2008 .

[3]  J. Lekakis,et al.  Target organ damage in "white coat hypertension" and "masked hypertension". , 2008, American journal of hypertension.

[4]  R. Fagard,et al.  Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis , 2007, Journal of hypertension.

[5]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[6]  J. Staessen,et al.  Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals , 2007, Journal of hypertension.

[7]  G. Stergiou,et al.  Cardiovascular risk prediction based on home blood pressure measurement: The Didima Study , 2007, Journal of hypertension.

[8]  K. Asayama,et al.  Plasma Fibrinogen, Ambulatory Blood Pressure, and Silent Cerebrovascular Lesions: The Ohasama Study , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[9]  TakeoKondo,et al.  Plasma Fibrinogen, Ambulatory Blood Pressure, and Silent Cerebrovascular Lesions , 2007 .

[10]  Ryusuke Inoue,et al.  Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: The Ohasama Study , 2007, Journal of hypertension.

[11]  Satoko Nakamura,et al.  Masked hypertension and target organ damage in treated hypertensive patients. , 2006, American journal of hypertension.

[12]  Roberto Sega,et al.  Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure , 2006, Hypertension.

[13]  Yutaka Imai,et al.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. , 2005, Journal of the American College of Cardiology.

[14]  Yutaka Imai,et al.  White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. , 2005, Archives of internal medicine.

[15]  T. Saruta.  [The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[16]  F. Magrini,et al.  Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients , 2005, Journal of Human Hypertension.

[17]  J. Schwartz,et al.  Short- and Long-Term Incidence of Stroke in White-Coat Hypertension , 2005, Hypertension.

[18]  Yutaka Imai,et al.  How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study , 2004, Journal of hypertension.

[19]  Gilles Chatellier,et al.  Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. , 2004, JAMA.

[20]  Hiroshi Hayashi,et al.  Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[21]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[22]  A. Hofman,et al.  Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.

[23]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[24]  A Hofman,et al.  Hypertension and cerebral white matter lesions in a prospective cohort study. , 2002, Brain : a journal of neurology.

[25]  A. de la Sierra,et al.  Silent cerebral white matter lesions in middle-aged essential hypertensive patients , 2002, Journal of hypertension.

[26]  M. Kikuya,et al.  INSUFFICIENT DURATION OF ACTION OF ANTIHYPERTENSIVE DRUGS MEDIATES HIGH BLOOD PRESSURE IN THE MORNINGIN HYPERTENSIVE POPULATION:THE OHASAMA STUDY , 2002, Clinical and experimental hypertension.

[27]  Roberto Sega,et al.  Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension: Data From the General Population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) , 2001, Circulation.

[28]  J. Schwartz,et al.  Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. , 2001, Journal of the American College of Cardiology.

[29]  W. White,et al.  Evaluation of the overall efficacy of the Omron office digital blood pressure HEM‐907 monitor in adults , 2001, Blood pressure monitoring.

[30]  M. Kikuya,et al.  Factors affecting the difference between screening and home blood pressure measurements: The Ohasama Study , 2001, Journal of hypertension.

[31]  M. Shin,et al.  Prevalence and risk factors of silent cerebral infarction in apparently normal adults. , 2000, HYPERTENSION.

[32]  R. Pini,et al.  Cardiac and Arterial Target Organ Damage in Adults with Elevated Ambulatory and Normal Office Blood Pressure , 1999, Annals of Internal Medicine.

[33]  R. Senior,et al.  Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. , 1998, Circulation.

[34]  H. Bokura,et al.  Subcortical silent brain infarction as a risk factor for clinical stroke. , 1997, Stroke.

[35]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[36]  Yutaka Imai,et al.  Characteristics of a community-based distribution of home blood pressure in Ohasama in northern Japan , 1993, Journal of hypertension.

[37]  K. Shimada,et al.  Silent Cerebrovascular Disease in the Elderly Correlation With Ambulatory Pressure , 1990, Hypertension.

[38]  Y. Imai,et al.  Clinical evaluation of semiautomatic and automatic devices for home blood pressure measurement: comparison between cuff-oscillometric and microphone methods , 1989, Journal of hypertension.

[39]  J. Laragh,et al.  How common is white coat hypertension? , 1988, JAMA.

[40]  W. Elliott.  Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study , 2010 .

[41]  W. Elliott.  Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis , 2008 .

[42]  W. Elliott.  White-Coat Hypertension as a Risk Factor for the Development of Home Hypertension: The Ohasama Study , 2006 .

[43]  Subcommittee Guidelines.  Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). , 2006, Hypertension research : official journal of the Japanese Society of Hypertension.

[44]  J. Staessen,et al.  Properly defining white coat hypertension. , 2002, European heart journal.

[45]  P. Palatini,et al.  Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. , 1998, Hypertension.

[46]  R H Fagard,et al.  Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. , 1997, Hypertension.

[47]  K. Kario,et al.  Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. , 1996, Hypertension.